Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06424821
Status:
RECRUITING
Last Update Posted:
2024-05-22
First Post:
2024-05-12
Brief Title:
Cadonilimab Plus Chemotherapy as First-line Treatment for PD-L1 Negative NSCLC
Sponsor:
Organization:
Shanghai Pulmonary Hospital Shanghai China